Catalyst Funds Management Pty LTD Aadi Bioscience, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 4,100 shares of AADI stock, worth $8,897. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,100Holding current value
$8,897% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AADI
# of Institutions
59Shares Held
12.8MCall Options Held
23.8KPut Options Held
0-
Avoro Capital Advisors LLC New York, NY2.85MShares$6.18 Million0.09% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2MShares$4.34 Million2.42% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$4.01 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.85MShares$4 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA766KShares$1.66 Million0.0% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $45.6M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...